Screening

HCC Screening among HBV Carriers May Be of Limited Benefit

Published in Cancer Weekly, September 18th, 1995

The incidence and prevalence of hepatocellular carcinoma (HCC) in hepatitis B carriers in North America urban areas may be as high as in countries endemic for hepatitis B virus (HBV).

Morris Sherman, M.D., Ph.D., and colleagues, the Toronto Hospital, and the University of Toronto, Toronto, Ontario, Canada, said they found such incidence and prevalence among patients in the greater Toronto area to be similar to that of patients in endemic areas ("Screening for Hepatocellular Carcinoma in Chronic Carriers of Hepatitis B Virus: Incidence and Prevalence of Hepatocellular Carcinoma in a North American Urban Population," Hepatology, August 1995;22(2):432-438).

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-09-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry